scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.CELLSIG.2008.07.020 |
P698 | PubMed publication ID | 18771726 |
P2093 | author name string | Lu Wang | |
Ting Li | |||
Taiping Shi | |||
Yanfei Zhang | |||
Dalong Ma | |||
Qihua He | |||
Wenling Han | |||
Yingmei Zhang | |||
Chuanfei Yu | |||
Quansheng Song | |||
Bingfeng Lv | |||
P2860 | cites work | Negative regulation of EGFR signalling through integrin-alpha1beta1-mediated activation of protein tyrosine phosphatase TCPTP | Q24321559 |
Bcl-2 targets the protein kinase Raf-1 to mitochondria | Q24321753 | ||
Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine | Q24322674 | ||
The role of protein tyrosine phosphatase 1B in Ras signaling | Q24622106 | ||
Large-scale mapping of human protein-protein interactions by mass spectrometry | Q24670192 | ||
Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding | Q27619633 | ||
Induction of neurite outgrowth in PC12 cells by alpha -phenyl-N-tert-butylnitron through activation of protein kinase C and the Ras-extracellular signal-regulated kinase pathway | Q28204706 | ||
14-3-3 zeta negatively regulates raf-1 activity by interactions with the Raf-1 cysteine-rich domain | Q28246442 | ||
Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization | Q28278217 | ||
The MAPK signaling cascade | Q28292599 | ||
Identification of Raf-1 S471 as a novel phosphorylation site critical for Raf-1 and B-Raf kinase activities and for MEK binding | Q28648013 | ||
14-3-3 Isotypes facilitate coupling of protein kinase C-ζ to Raf-1: negative regulation by 14-3-3 phosphorylation | Q29041812 | ||
The structural basis for 14-3-3:phosphopeptide binding specificity | Q29547190 | ||
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases | Q29614338 | ||
The RAF proteins take centre stage | Q29620153 | ||
Imaging of cell migration | Q30477789 | ||
14-3-3 acts as an intramolecular bridge to regulate cdc25B localization and activity | Q33292430 | ||
How do 14-3-3 proteins work?-- Gatekeeper phosphorylation and the molecular anvil hypothesis | Q34120299 | ||
Identification of novel in vivo Raf-1 phosphorylation sites mediating positive feedback Raf-1 regulation by extracellular signal-regulated kinase | Q34407252 | ||
14-3-3 proteins: active cofactors in cellular regulation by serine/threonine phosphorylation | Q34439988 | ||
Protein tyrosine phosphatase interacting protein 51 (PTPIP51) is a novel mitochondria protein with an N-terminal mitochondrial targeting sequence and induces apoptosis | Q34544761 | ||
Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis | Q34607187 | ||
Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations | Q34991305 | ||
Unlocking the code of 14-3-3. | Q35748302 | ||
Regulation of tumor cell motility by ERK mitogen-activated protein kinases | Q36014066 | ||
Negative regulation of Raf-1 by phosphorylation of serine 621. | Q40019933 | ||
CMTM5 exhibits tumor suppressor activities and is frequently silenced by methylation in carcinoma cell lines | Q40073739 | ||
Epidermal growth factor-, transforming growth factor-beta-, retinoic acid- and 1,25-dihydroxyvitamin D3-regulated expression of the novel protein PTPIP51 in keratinocytes | Q40158832 | ||
Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration | Q40393756 | ||
Regulation of Raf-1 by direct feedback phosphorylation. | Q40467820 | ||
Hepatocyte growth factor induces ERK-dependent paxillin phosphorylation and regulates paxillin-focal adhesion kinase association | Q40757992 | ||
Bcr and Raf form a complex in vivo via 14-3-3 proteins | Q40789573 | ||
Association of the protein kinases c-Bcr and Bcr-Abl with proteins of the 14-3-3 family | Q41436352 | ||
The novel protein PTPIP51 exhibits tissue- and cell-specific expression | Q42472048 | ||
Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras. | Q42800762 | ||
14-3-3 dimers probe the assembly status of multimeric membrane proteins | Q44406301 | ||
Threshold levels of ERK activation for chemotactic migration differ for NGF and EGF in rat pheochromocytoma PC12 cells | Q46479843 | ||
The RAF family: an expanding network of post-translational controls and protein-protein interactions. | Q47823131 | ||
Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. | Q53335960 | ||
A brake becomes an accelerator: PTP1B--a new therapeutic target for breast cancer. | Q54383166 | ||
Roles for the protein tyrosine phosphatase SHP-2 in cytoskeletal organization, cell adhesion and cell migration revealed by overexpression of a dominant negative mutant | Q73379065 | ||
The dominant negative Ras mutant, N17Ras, can inhibit signaling independently of blocking Ras activation | Q73561161 | ||
Expression of the novel protein PTPIP51 in rat liver: an immunohistochemical study | Q80435058 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell morphology | Q66568582 |
P304 | page(s) | 2208-20 | |
P577 | publication date | 2008-12-01 | |
P1433 | published in | Cellular Signalling | Q1524097 |
P1476 | title | PTPIP51, a novel 14-3-3 binding protein, regulates cell morphology and motility via Raf-ERK pathway | |
P478 | volume | 20 |
Q38654834 | Altered Protein Interactions of the Endogenous Interactome of PTPIP51 towards MAPK Signaling |
Q37505664 | Cell and molecular biology of the novel protein tyrosine-phosphatase-interacting protein 51. |
Q64058529 | Crosstalks of the PTPIP51 interactome revealed in Her2 amplified breast cancer cells by the novel small molecule LDC3/Dynarrestin |
Q34915802 | Differentiation-dependent PTPIP51 expression in human skeletal muscle cell culture |
Q58709253 | Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells |
Q43257781 | Expression profile of PTPIP51 in mouse brain |
Q92502754 | IRSp53 coordinates AMPK and 14-3-3 signaling to regulate filopodia dynamics and directed cell migration |
Q33649607 | Interaction of PTPIP51 with Tubulin, CGI-99 and Nuf2 During Cell Cycle Progression |
Q38979223 | Orchestrating cellular signaling pathways-the cellular "conductor" protein tyrosine phosphatase interacting protein 51 (PTPIP51). |
Q34271712 | PTPIP51 in protein interactions: regulation and in situ interacting partners |
Q83297453 | PTPIP51 interaction with PTP1B and 14-3-3β in adipose tissue of insulin-resistant mice |
Q38888799 | PTPIP51 levels in glioblastoma cells depend on inhibition of the EGF-receptor. |
Q24338749 | PTPIP51-a myeloid lineage specific protein interacts with PTP1B in neutrophil granulocytes |
Q36711714 | PTPIP51: a new interaction partner of the insulin receptor and PKA in adipose tissue |
Q35833989 | PTPIP51—A New RelA-tionship with the NFκB Signaling Pathway |
Q30400364 | Protein tyrosine phosphatase interacting protein 51--a jack-of-all-trades protein |
Q58581282 | The Importance of the Right Framework: Mitogen-Activated Protein Kinase Pathway and the Scaffolding Protein PTPIP51 |
Q60958881 | The Interface Between ER and Mitochondria: Molecular Compositions and Functions |
Q50700672 | The overexpression of Rabl3 is associated with pathogenesis and clinicopathologic variables in hepatocellular carcinoma. |
Q24298739 | VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis |
Search more.